Recursion Pharmaceuticals Announces Upcoming Investor Conferences
Recursion (NASDAQ: RXRX), a pioneering clinical-stage TechBio company dedicated to transforming biology for better health outcomes, reveals its forthcoming engagement in significant investor conferences. These events provide an exciting opportunity for Recursion to showcase its innovative technology and mission to revolutionize healthcare.
Key Conferences Highlighted
The conferences Recursion will participate in include:
Guggenheim 2nd Annual Healthcare Innovation Conference
The event is set for November 11, an important venue for stakeholders in the healthcare innovation space. Attendees can expect insightful discussions about cutting-edge advancements and strategies for progress.
Jefferies Global Healthcare Conference in London
Scheduled for November 18, this conference serves as a major platform where healthcare leaders come together to share insights and drive new collaborations. Recursion is looking forward to participating in these discussions.
Where to Find Webcasts
Investors interested in Recursion’s updates can access live webcasts and additional information through the events section on the Recursion Investor Relations website. This platform serves as a vital resource for all relevant communications regarding the company's activities and future endeavors.
About Recursion Pharmaceuticals
Recursion (NASDAQ: RXRX) is at the forefront of the TechBio sector, utilizing advanced technologies to decode biological processes for significant therapeutic advancements. Their mission is underpinned by the Recursion OS, an innovative platform that integrates a wealth of proprietary biological and chemical data. This unique system allows Recursion to employ sophisticated machine-learning algorithms that unearth numerous, previously unknown relationships across various biological entities.
By conducting millions of wet lab experiments on a weekly basis and utilizing one of the world’s most powerful supercomputers, Recursion is poised to lead the integration of technology with biology and chemistry. This multidisciplinary approach enables them to push the boundaries of conventional medicine and tackle complex health conditions more effectively.
Expanding Footprint in the Life Sciences Sector
Headquartered in Salt Lake City, Recursion is a proud founding member of BioHive, the collaborative network of the Utah life sciences community. With additional offices in cities such as Montréal, New York, London, and Oxford, Recursion is well-positioned to contribute to global healthcare advancements.
Investor and Media Contact Information
For investor inquiries, please reach out to investor@recursion.com. For media inquiries, contact media@recursion.com.
Frequently Asked Questions
What is Recursion Pharmaceuticals focused on?
Recursion Pharmaceuticals is focused on transforming biology through innovative technologies to improve healthcare outcomes.
When are the upcoming investor conferences?
The upcoming conferences are on November 11 and November 18.
How can I access the webcasts of the investor conferences?
Webcasts can be accessed through the events section on the Recursion Investor Relations website.
Where is Recursion headquartered?
Recursion is headquartered in Salt Lake City and has additional offices in various cities including Montréal and New York.
What technologies does Recursion employ?
Recursion utilizes a unique platform that integrates vast biological and chemical datasets to apply machine learning in their research and development efforts.